StockData
DSSNYSEPaperboard Containers & BoxesFiscal year ends December 31

DSS, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.58−0.03 (-4.89%)

Close on Oct 19, 2026

Market cap
$5.83M
P/E (TTM)
–
Dividend yield
–

DSS, INC. revenue by segment

By business segment

RevenueQ2 26Q1 26Q4 25Q3 25Q2 25Q1 25Q4 24Q3 24Q2 24Q1 24Q4 23Q3 23% of revenueYoY
Product Packaging [Member]$3.27M$4.16M$4.93M$4.94M$4.29M$4.00M$4.64M$4.85M$3.54M$3.08M$5.61M$3.38M90.8%-23.6%
Securities [Member]$321.00K$155.00K–$1.44M$981.00K$920.00K$746.00K$707.00K$624.00K$687.00K$1.61M$173.00K8.9%-67.3%
Securities Revenue Information [Member]$321.00K$155.00K–$1.44M$981.00K$920.00K$746.00K$707.00K––––8.9%-67.3%
Commercial Banking [Member]$6.00K$6.00K––$9.00K$21.00K$34.00K$45.00K$44.00K$104.00K–$108.00K0.2%-33.3%
Commercial Lending Revenue Information [Member]$6.00K$6.00K$8.00K$7.00K$9.00K$21.00K$34.00K$45.00K––––0.2%-33.3%
Biotechnology [Member]$3.00K$7.00K$6.00K$11.00K$7.00K$15.00K–$1.00K$1.00K$2.00K––0.1%-57.1%
Biotechnology Revenue Information [Member]$3.00K$7.00K$6.00K$11.00K$7.00K$15.00K–$1.00K––––0.1%-57.1%
Direct Marketing Online Sales [Member]–––––––$0$3.00K–$0$523.00K––
Commercial Lending [Member]–––$7.00K$9.00K$21.00K–$45.00K$44.00K$102.00K––––
Operating incomeQ2 26Q1 26Q4 25Q3 25Q2 25Q1 25Q4 24Q3 24Q2 24Q1 24Q4 23Q3 23YoY
Commercial Banking [Member]-$88.00K-$71.00K––-$300.00K-$23.00K-$23.00K-$311.00K––-$31.02M-$31.00K-70.7%
Biotechnology [Member]-$697.00K-$2.30M-$1.30M-$884.00K-$1.19M-$1.05M-$26.31M-$1.18M-$671.00K-$811.00K-$1.21M-$1.16M-41.5%
Corporate Segment [Member]-$874.00K-$686.00K$10.66M-$11.07M-$453.00K-$1.50M-$617.00K-$654.00K-$775.00K-$736.00K-$975.00K-$866.00K+92.9%
Product Packaging [Member]-$956.00K-$1.18M-$419.00K-$339.00K-$560.00K-$512.00K-$590.00K-$270.00K-$882.00K-$411.00K$567.00K-$1.14M+70.7%
Securities [Member]-$1.17M-$1.26M-$5.39M$1.33M-$921.00K-$638.00K-$736.00K-$2.19M-$2.44M-$2.18M-$1.84M-$2.11M+27.1%
Direct Marketing Online Sales [Member]–––$7.59M-$27.00K-$34.00K-$37.00K-$71.00K-$91.00K-$60.00K-$726.00K$197.00K–
Commercial Lending [Member]–––$142.00K-$300.00K-$23.00K–-$311.00K-$76.00K-$481.00K–––

By product or service

RevenueQ2 26Q1 26Q4 25Q3 25Q2 25Q1 25Q4 24Q3 24Q2 24Q1 24Q4 23Q3 23% of revenueYoY
Printed Products Revenue Information [Member]$3.27M$4.16M$4.93M$4.94M$4.29M$4.00M$4.64M$4.85M––––90.8%-23.6%
Printed Products [Member]$3.26M$4.15M––$4.27M$3.98M$4.68M$4.83M$3.53M$3.07M$5.52M$3.32M90.4%-23.7%
Rental [Member]$245.00K–––$715.00K–––––––6.8%-65.7%
Commission [Member]$92.00K–––$282.00K–––––––2.6%-67.4%
Commercial Lending [Member]$6.00K$6.00K––$9.00K$21.00K––––––0.2%-33.3%
Biotechnology [Member]$3.00K–––$7.00K–––––––0.1%-57.1%
Direct Marketing [Member]––––––––––$0$523.00K––
Rental Income [Member]–$148.00K––$715.00K$714.00K$458.00K$496.00K$438.00K$400.00K$183.00K$236.00K––
Net Investment Income [Member]––––$9.00K$21.00K$45.00K$45.00K$41.00K$95.00K–$108.00K––
Commission Revenue [Member]–$23.00K–$662.00K$282.00K$221.00K$235.00K$230.00K$204.00K$303.00K$1.35M$0––
Net Investment Revenue Income [Member]–––––––$45.00K$41.00K$102.00K–$108.00K––
Rental Revenue Income [Member]–––––––$496.00K$438.00K$400.00K$183.00K$236.00K––
Securities Revenue [Member]––––$981.00K$920.00K––$624.00K$687.00K––––
Direct Marketing [Member]––––––––$0$2.00K––––
Printed Products Revenue [Member]–––$4.99M$4.29M$4.00M–$4.83M$3.54M$3.08M––––
Biotechnology Marketing [Member]––––$7.00K$15.00K––$1.00K–––––
Biotechnology Retail Sales [Member]–$7.00K––$7.00K$15.00K––$1.00K–––––
Rental Revenue [Member]–––$718.00K–––$496.00K––––––
Net Investment Revenue [Member]–––$7.00K–––$45.00K––––––
Biotechnology Retail Revenue [Member]–––$11.00K––––––––––

By region

From the segment and revenue-disaggregation notes of DSS's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.